Acquisition Creates National Specialty Nursing Platform Focused on Rare Disease and Specialty Infusion Patients
MADISONVILLE, LA / ACCESS Newswire / August 4, 2026 / Pharma Fusion, a leading national specialty pharmacy serving patients with rare and complex conditions, today announced the acquisition of 25 Degree Nursing, a national provider of specialty nursing services supporting patients receiving complex infusion therapies. The acquisition establishes Pharma Fusion's national specialty nursing division and expands the company's ability to deliver fully integrated pharmacy and nursing services nationwide.
The acquisition marks a significant milestone in Pharma Fusion's continued growth as a comprehensive specialty healthcare partner. By integrating specialty pharmacy with a national network of experienced nurses, the company will provide more coordinated care throughout every stage of the patient journey, strengthening collaboration among providers, pharmacists, nurses, patients, and caregivers while improving continuity of care.
The new nursing division launches with a nationwide network of approximately 1,000 specialized nurses experienced in caring for patients with rare and complex chronic diseases. The clinical expertise that this team of nurses brings to Pharma Fusion includes Immunoglobulin National Certification (IgCN®), Bleeding Disorders, Hereditary Angioedema (HAE), Alpha-1 Antitrypsin Deficiency (AATD), Enzyme Replacement Therapies (ERT), and a broad range of specialty infusion therapies. The integrated platform supports Pharma Fusion's core therapeutic areas and enhances its ability to deliver coordinated, patient-centered care.
"The acquisition of 25 Degree Nursing represents an important step in our long-term vision of providing truly integrated specialty care," said Rick Rodrigue, Chief Executive Officer of Pharma Fusion. "Patients managing rare and complex conditions deserve a coordinated experience where pharmacy and nursing work together as one team. This acquisition allows us to strengthen clinical oversight, improve continuity of care, and better support patients wherever they receive treatment."
The acquisition also strengthens Pharma Fusion's ability to serve physicians, manufacturers, health plans, and healthcare partners seeking a single organization capable of delivering both specialty pharmacy and in-home nursing services for a complete and comprehensive patient journey. As demand for specialty infusion and rare disease therapies continues to grow, Pharma Fusion remains focused on expanding access to high-quality clinical care while improving patient outcomes through a vertically integrated care model.
About Pharma Fusion:
Pharma Fusion is a national specialty pharmacy dedicated to providing advanced therapeutic solutions for patients living with rare and complex chronic conditions. Through nationwide licensure and expertise in specialty medications, infusion therapies, and comprehensive clinical services, Pharma Fusion partners with patients, providers, manufacturers, and payers to deliver personalized, coordinated care throughout the treatment journey.
About 25 Degree Nursing:
25 Degree Nursing is a national nursing platform focused on providing specialized nursing services to patients receiving specialty infusion therapies. The company supports patients with complex and rare conditions by coordinating experienced nurses and delivering care in the home and other appropriate settings.
Media Contact:
Caitlin Henderson
Chief Administrative Officer
Pharma Fusion
Email: chenderson@pharmafusionrx.com
SOURCE: Pharma Fusion
View the original press release on ACCESS Newswire